L-GLUTAMINE 2250
Natural health product licensed in Canada
- Other names
- NST L-GLUTAMINE 2250, NST L-GLUTAMINE Tabs 2250
- Licence holder
- NEKSPORTEK Corporation
- NPN or DIN-HM
- 80030643
- Status
- Active licence
- Licence date
- 20 March 2012
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| L-Glutamine Source : L-Glutamine | 2.25 g | Not calculated |
Non-medicinal ingredients
Silice, Acide ascorbique, Stéarate de calcium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Comprimé | 2 Tous les jours |
Uses authorised in Canada
Aide à la réparation de cellules musculaires suite à de l'exercice physique. Aide à restaurer les niveaux sanguins de glutamine appauvris suite à des périodes de stress physique (e.g. de l'exercice physique intense et prolongé). Aide au maintien de la santé du système digestif suite à des périodes de stress physique. Aide au maintien de la santé du système immunitaire suite à des périodes de stress physique.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80030643
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.